BNP Paribas Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7K Sell
144
-25
-15% -$2.38K ﹤0.01% 2094
2025
Q4
$14K Buy
169
+35
+26% +$3.01K ﹤0.01% 2053
2025
Q3
$12K Buy
134
+15
+13% +$1.34K ﹤0.01% 1570
2025
Q2
$10K Buy
+119
New +$9.95K ﹤0.01% 1772

Other funds holding LMAT

BNP Paribas Asset Management's LMAT Position: Q1 2026 in Review

BNP Paribas Asset Management reduced its LeMaitre Vascular (LMAT) stake by 15% in Q1 2026, selling an estimated $2.38K and leaving 144 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

BNP Paribas Asset Management first reported a position in LMAT in Q2 2025 and has held it in 4 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • BNP Paribas Asset Management held 144 shares of LeMaitre Vascular worth $15.7K as of Q1 2026.
  • BNP Paribas Asset Management sold 25 LeMaitre Vascular shares in Q1 2026, an estimated $2.38K.
  • LeMaitre Vascular made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #2094 holding.
  • BNP Paribas Asset Management first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 4 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.